Top compounds associated with response to MRPL9

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	navitoclax:PLX-4032 (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.21	2e-09
mRNA	UNC0638:navitoclax (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.22	6e-09
mRNA	ABT-263	CTRPv2	pan-cancer	AAC	-0.21	8e-09
mRNA	ABT-737	CTRPv2	pan-cancer	AAC	-0.21	1e-08
mRNA	navitoclax:pluripotin (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.2	3e-08
mRNA	BRD-A02303741:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.2	4e-08
mRNA	decitabine:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.17	5e-08
mRNA	navitoclax:piperlongumine (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.19	2e-07
mRNA	selumetinib:navitoclax (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.19	2e-07
mRNA	navitoclax:birinapant (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.18	6e-07

Download CSV